Kuros: Kuros raises CHF12.5 million

Kuros Biosciences has announced the final number of gross proceeds from the Rights Offering and Share Offering, first announced on November 19, 2019. Total gross proceeds raised from the Capital Increase amount to CHF 12.5 million. The proceeds will be used for the commercialization of the products and the further development of product candidates.